Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice

Pharmacokinetic data for riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) have previously been reported from randomized clinical trials, which may not fully reflect the population encountered in routine practice. The aim of the current study was to characterize the ph...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pulm Circ
Hlavní autoři: Michaličková, Danica, Jansa, Pavel, Bursová, Miroslava, Hložek, Tomáš, Čabala, Radomír, Hartinger, Jan Miroslav, Ambrož, David, Aschermann, Michael, Lindner, Jaroslav, Linhart, Aleš, Slanař, Ondřej, Krekels, Elke H.J.
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011339/
https://ncbi.nlm.nih.gov/pubmed/32095231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894019898031
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky